TOURMALINE BIO INC
HQ - New York, NY
Summary
Tourmaline Bio is a biopharmaceutical company focused on developing pacibekitug, an anti-IL-6 mAb, as a treatment option for atherosclerotic cardiovascular disease.
Deals Overview
Total Deals2
Valued Deals1
Total Value£ 1.03 B
Avg. Deal Size£ 1.03 B
Senior Management
Sandeep Kulkarni
Co-Founder and CEO
Ryan Robinson
CFO
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite